PainBalance features a series of exclusive, high-quality, three-dimensional instructional animations that provide easy-to-understand information on the complex aspects of pain and pain management.
PainBalance also provides instructional and presentation materials to help doctors mentor their peers, thus improving healthcare professionals’ understanding of proper pain management.
Helping to keep healthcare professionals up-to-date on all aspect of pain management, PainBalance will provide the latest information on research, advances in treatment, issues on policy and reimbursement, and other important news.
To learn more about the PainBalance educational initiative, the high burden of undertreated chronic pain, and to preview the tools and resources available to healthcare professionals and others, visit www.painbalance.org.
About King Pharmaceuticals, Inc.
King, headquartered in Bristol, Tennessee, is a vertically integrated branded pharmaceutical company. King, an S&P 500 Index company, seeks to capitalize on opportunities in the pharmaceutical industry through the development, including through in-licensing arrangements and acquisitions, of novel branded prescription pharmaceutical products and technologies that complement the Company’s focus in specialty-driven markets, particularly neuroscience and hospital. King’s wholly owned subsidiary, Alpharma Inc., is also a leader in the development, registration, manufacture, and marketing of pharmaceutical products for food-producing animals.
1. National Pain Survey, Conducted for Ortho-McNeil Pharmaceuticals, 1999.
2. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: General Information and
Copyright©2010 Vocus, Inc.
All rights reserved